Want to see SE:BIOG.B full AI Analyst Report?
BioGaia AB (BIOG.B) Ratios
BioGaia AB Ratios
SE:BIOG.B's free cash flow for Q3 2026 was $67.83M. For the 2026 fiscal year, SE:BIOG.B's free cash flow was decreased by $-11.97M and operating cash flow was $79.80M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.12 | 7.81 | 9.58 | 10.89 | 13.80 |
| Quick Ratio | 6.12 | 7.07 | 8.65 | 10.03 | 12.99 |
| Cash Ratio | 4.02 | 5.94 | 7.89 | 9.02 | 11.69 |
| Solvency Ratio | 1.26 | 1.38 | 1.29 | 1.65 | 0.87 |
| Operating Cash Flow Ratio | 1.54 | 1.81 | 2.18 | 1.93 | 1.75 |
| Short-Term Operating Cash Flow Coverage | 44.43 | 0.00 | 0.00 | -34.78 | -16.79 |
| Net Current Asset Value | $ 935.49M | $ 1.30B | $ 1.57B | $ 1.56B | $ 1.50B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.22 | 1.18 | 1.15 | 1.12 | 1.13 |
| Debt Service Coverage Ratio | 23.84 | 29.68 | 483.86 | -106.49 | -18.24 |
| Interest Coverage Ratio | 48.84 | 28.37 | 547.72 | 67.11 | 224.15 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 |
| Interest Debt Per Share | 0.15 | 0.22 | 0.10 | 0.25 | 0.11 |
| Net Debt to EBITDA | -1.75 | -2.26 | -3.10 | -3.08 | -5.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 73.37% | 72.45% | 73.29% | 72.64% | 74.25% |
| EBIT Margin | 27.93% | 32.53% | 36.22% | 41.03% | 32.33% |
| EBITDA Margin | 29.54% | 37.92% | 38.17% | 43.20% | 35.26% |
| Operating Profit Margin | 26.82% | 29.76% | 34.18% | 32.74% | 32.32% |
| Pretax Profit Margin | 27.38% | 31.48% | 36.16% | 40.55% | 32.19% |
| Net Profit Margin | 21.63% | 24.70% | 28.18% | 33.86% | 25.00% |
| Continuous Operations Profit Margin | 21.63% | 24.70% | 28.18% | 33.86% | 25.00% |
| Net Income Per EBT | 79.00% | 78.47% | 77.93% | 83.50% | 77.67% |
| EBT Per EBIT | 102.12% | 105.77% | 105.81% | 123.84% | 99.60% |
| Return on Assets (ROA) | 20.83% | 17.28% | 15.66% | 16.88% | 9.22% |
| Return on Equity (ROE) | 25.32% | 20.38% | 17.99% | 18.95% | 10.45% |
| Return on Capital Employed (ROCE) | 29.49% | 23.16% | 20.73% | 17.64% | 12.68% |
| Return on Invested Capital (ROIC) | 23.18% | 18.10% | 16.09% | 14.72% | 9.86% |
| Return on Tangible Assets | 22.94% | 18.91% | 17.22% | 18.72% | 10.17% |
| Earnings Yield | 3.10% | 3.11% | 3.53% | 4.43% | 1.88% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.50 | 6.40 | 11.51 | 8.45 | 6.62 |
| Payables Turnover | 7.23 | 8.12 | 7.02 | 32.35 | 4.78 |
| Inventory Turnover | 0.00 | 2.56 | 1.91 | 2.11 | 1.97 |
| Fixed Asset Turnover | 8.49 | 6.92 | 6.08 | 7.00 | 5.11 |
| Asset Turnover | 0.96 | 0.70 | 0.56 | 0.50 | 0.37 |
| Working Capital Turnover Ratio | 1.27 | 0.92 | 0.78 | 0.68 | 0.49 |
| Cash Conversion Cycle | 5.62 | 154.47 | 170.72 | 204.55 | 164.23 |
| Days of Sales Outstanding | 56.12 | 57.08 | 31.71 | 43.21 | 55.13 |
| Days of Inventory Outstanding | 0.00 | 142.37 | 190.98 | 172.62 | 185.49 |
| Days of Payables Outstanding | 50.50 | 44.98 | 51.97 | 11.28 | 76.40 |
| Operating Cycle | 56.12 | 199.44 | 222.69 | 215.83 | 240.62 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.03 | 3.69 | 4.22 | 3.16 | 2.20 |
| Free Cash Flow Per Share | 2.99 | 3.55 | 3.74 | 2.98 | 2.13 |
| Dividend Paid and CapEx Coverage Ratio | 0.44 | 0.52 | 1.25 | 1.00 | 2.95 |
| Capital Expenditure Coverage Ratio | 85.18 | 26.37 | 8.74 | 17.80 | 34.78 |
| Operating Cash Flow Coverage Ratio | 44.43 | 52.57 | 48.41 | 15.88 | 21.33 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.26 | 0.33 | 0.29 | 0.28 |
| Free Cash Flow Yield | 2.82% | 3.17% | 3.64% | 3.57% | 2.06% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 32.28 | 32.19 | 28.33 | 22.58 | 53.30 |
| Price-to-Sales (P/S) Ratio | 6.98 | 7.95 | 7.98 | 7.64 | 13.33 |
| Price-to-Book (P/B) Ratio | 8.17 | 6.56 | 5.10 | 4.28 | 5.57 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 35.46 | 31.50 | 27.44 | 28.03 | 48.55 |
| Price-to-Operating Cash Flow Ratio | 35.04 | 30.30 | 24.30 | 26.46 | 47.15 |
| Price-to-Earnings Growth (PEG) Ratio | -6.22 | -7.77 | -13.10 | 0.25 | 5.93 |
| Enterprise Value Multiple | 21.90 | 18.71 | 17.81 | 14.62 | 32.46 |
| Enterprise Value | 9.95B | 10.09B | 8.82B | 6.97B | 8.99B |
| EV to EBITDA | 21.90 | 18.71 | 17.81 | 14.62 | 32.46 |
| EV to Sales | 6.47 | 7.09 | 6.80 | 6.31 | 11.45 |
| EV to Free Cash Flow | 32.84 | 28.11 | 23.37 | 23.16 | 41.71 |
| EV to Operating Cash Flow | 32.45 | 27.04 | 20.69 | 21.86 | 40.51 |
| Tangible Book Value Per Share | 11.54 | 15.32 | 18.01 | 17.38 | 16.64 |
| Shareholders’ Equity Per Share | 12.99 | 17.06 | 20.11 | 19.53 | 18.59 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.22 | 0.22 | 0.16 | 0.22 |
| Revenue Per Share | 15.20 | 14.08 | 12.84 | 10.93 | 7.77 |
| Net Income Per Share | 3.29 | 3.48 | 3.62 | 3.70 | 1.94 |
| Tax Burden | 0.79 | 0.78 | 0.78 | 0.84 | 0.78 |
| Interest Burden | 0.98 | 0.97 | 1.00 | 0.99 | 1.00 |
| Research & Development to Revenue | 0.08 | 0.11 | 0.08 | 0.10 | 0.13 |
| SG&A to Revenue | 0.36 | 0.33 | 0.03 | 0.04 | 0.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.74 | 1.06 | 0.96 | 0.88 | 0.87 |
Currency in SEK
